Tyche Industries Limited is an India-based company engaged in manufacturing of active pharmaceutical ingredients (APIs) and advanced intermediates of APIs. The Company operates through the Bulk Drugs segment. Its APIs include Sertraline HCI, Racecadotril, Palonosetron HCI, Silodosin, Solifenacin Succinate, Tamsulosin HCI, Tenofovir Disoproxil Fumarate, Tenofovir Alafenamide Fumarate, Atazanavir, Rupatadine Fumarate, Glucosamine HCI, Glucosamine Sulfate KCL, Glucosamine Sulfate NaCl, Nitrofurantoin Monohydrate, Nitrofurantoin Anhydrous and Nitrofurantoin Macrocrystal and others. Its intermediates include 4-(3,4-Dichlorophenyl)-1-tetralone, 1-Benzylpiperidine-4-Carboxaldehyde (BPCA), 3-Hydroxymethyl quinuclidine Hcl, and others. Its chiral intermediates include S-(+)-3-Quinuclidinol, R-(-)-3-Quinuclidinol and others. The Company's nutraceuticals include Glucosamine Hydrochloride, Glucosamine Sulfate Potassium Chloride and Glucosamine Sulfate Sodium Chloride.
TYCHE INDUSTRIES LTD. Financial Highlights
- Revenue: TYCHE INDUSTRIES LTD. reported revenue of ₹62.85 crore in FY26 vs ₹72.89 crore in FY25. It showed a decrease of 13.77% on a yearly basis.
- Operating Profit: TYCHE INDUSTRIES LTD. reported an operating profit of ₹9.46 crore in FY26 vs ₹16.71 crore in FY25. It showed a decrease of 43.39% on a year-on-year basis.
- Net Profit: TYCHE INDUSTRIES LTD. reported a net profit of ₹6.94 crore in FY26 vs ₹12.41 crore in FY25. It showed a decrease of 44.08% on a yearly basis.
TYCHE INDUSTRIES LTD. Quarterly Result Highlights
- TYCHE INDUSTRIES LTD. reported revenue of ₹19.16 crore in Mar 2026, compared with ₹12.43 crore in Dec 2025, representing an increase of 54.14% on a quarter-on-quarter (QoQ) basis.
- TYCHE INDUSTRIES LTD. reported an operating profit of ₹1.70 crore in Mar 2026, compared with ₹2.46 crore in Dec 2025, representing a decrease of 30.89% on a quarter-on-quarter (QoQ) basis.
- TYCHE INDUSTRIES LTD. reported a profit of ₹1.15 crore in Mar 2026, compared with ₹1.82 crore in Dec 2025, reflecting a decrease of 36.81% on a QoQ basis.
- The earnings per share (EPS) of TYCHE INDUSTRIES LTD. stood at ₹12.20 during Mar 2026.